<DOC>
	<DOCNO>NCT01791920</DOCNO>
	<brief_summary>To compare safety efficacy Botulax速 Botox速 improvement moderate severe glabellar line .</brief_summary>
	<brief_title>To Evaluate Safety Efficacy Botulax速 Are Not Inferior Those Botox速 Treatment Glabellar Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Men woman age 18 65 Patients attain grade 2 3 investigator 's rating glabellar line severity maximum frown Patients voluntarily sign informed consent Patients comply study procedure visit schedule Subjects facial plastic surgery ( tissue augmentation , brow lift , dermal resurface ) treatment within 6 month . Those peel laser therapy Subjects skin disorder , scar infection around glabellar region Subjects take Aspirin , NSAIDS anticoagulant Subjects facial palsy eyelid ptosis Subjects diagnose neuromuscular junction disorder ( e.g. , myasthenia gravis , LambertEaton Syndrome ) Subjects history drug intoxication , alcohol abuse and/or depressive disorder Subjects severe internal disease ( cardiovascular , respiratory , renal disease , liver disorder ) Subjects previously treat botulinum toxin within 3 month ( Botulinum toxin type A : 3months , type B : 4 month ) Subject administer follow drug within previous 4 month : Spectinomycin Hydrochloride , Aminoglycoside antibiotic , polypeptide antibiotic , tetracycline antibiotic , lincomycin antibiotic , muscle relaxant , anticholinergic agent , benzodiazepine similar drug , benzamide drug , Tubocurarinetype muscle relaxant Subjects possibility take drug list Subjects plan receive facial cosmetic procedure include dermal filler , chemical peel dermabrasion study period Subjects glabellar line unable improved physical method Subjects history hypersensitivity Botulinum toxin agent Subjects pregnant breastfeed Subjects plan pregnant 3months , contraceptive Subjects participate study within 30 day pass 5 time half life investigational product Subjects trouble acute disease Subjects take treatment affect glabellar line and/or line around forehead within previous 6 month Subjects unable communicate follow instruction Subjects eligible study base investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>